期刊名称：MOLECULAR AND BIOCHEMICAL PARASITOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
MOLECULAR AND BIOCHEMICAL PARASITOLOGY
The journal provides a medium for the rapid publication of investigations of the molecular biology, molecular immunology and biochemistry of parasitic protozoa and helminths and their interactions with both the definitive and intermediate host. The main subject areas covered are: chemical structure, biosynthesis, degradation, properties and function of small molecular weight substances, DNA, RNA, proteins, lipids and carbohydrates - intermediary metabolism and bioenergetics - molecular and biochemical studies on the mode of action of antiparasitic drugs - molecular and biochemical aspects of membrane structure and function - molecular and biochemical aspects of host-parasite relationships including analysis of parasitic escape mechanisms - characterisation of parasite antigen and parasite and host cell surface receptors - characterisation of genes by biophysical and biochemical methods, including recombinant DNA technology - analysis of gene structure, function and expression - mechanisms of genetic recombination.
|
Abstracting / Indexing
Abstracts in Hygiene and Communicable Diseases BIOSIS; Chemical Abstracts; Current Contents/Life Sciences; EMBASE; Elsevier BIOBASE; Helminthological Abstracts; Index Medicus; Pascal et Francis (INST-CNRS); Protozoological Abstracts; Reference Update; Tropical Diseases Bulletin |
 |
Instructions to Authors
Contact details for submission
Andy Waters
Institute of Biomedical Life Sciences & Wellcome Centre for Molecular Parasitology,
Division of Infection and Immunity,
Glasgow Biomedical Research Centre, University of Glasgow,
120 University Place,
Glasgow, Scotland, UK.
E-mail: Waters@bio.gla.ac.uk
Phil LoVerde
University of Texas,
Departments of Biochemistry and Pathology,
Mail Code 7760, Health Science Center,
San Antonio, Texas 78229-3900, USA.
Email: loverde@uthscsa.edu
Marilyn. Parsons
Seattle Biomedical Research Institute,
307 Westlake Avenue, N, Suite 500,
Seattle, WA 98109-5219, USA.
Email: marilyn.parsons@sbri.org
Keith Matthews
University of Edinburgh, Institute of Immunology and Infection Research,
School of Biological Sciences,
Ashworth Laboratories, West Mains Road,
Edinburgh, EH9 3JT, Scotland, UK.
Email: keith.matthews@ed.ac.uk
Reviews Editor
Alister Craig
Liverpool School of Tropical Medicine,
Pembroke Place, Liverpool L3 5QA, UK.
E-mail:agcraig@liverpool.ac.uk
Ethics in Publishing
For information on Ethics in Publishing and Ethical guidelines for journal publication see  http://www.elsevier.com/publishingethics and http://www.elsevier.com/ethicalguidelines.
Policy and ethics
Ethics of experimentation
Submitted papers must contain precise details on the care and use of animals and of experimental procedures, especially interventions such as surgery and tissue sampling, and methods of euthanasia. Authors are expected to comply with all relevant institutional and governmental policies, regulations, and guidelines regarding the ethical treatment of experimental animals. Authors should record their compliance with such policies, regulations, and guidelines, as implemented under protocols developed by the relevant institution(s) with which authors are affiliated, in the Methods section of their manuscripts. The editors reserve the right to request documentation of such compliance. If experimental animals are used for growth of parasites when an in vitro culture system is available for the species in question, a specific justification for this must be provided.
Furthermore, referees are asked to indicate whether there is any reason to consider that experimental animals were used unnecessarily, not well treated or care was not taken to avoid distress. Papers may ultimately be rejected upon such grounds.
Conflict of interest
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also http://www.elsevier.com/conflictsofinterest.
Submission declaration
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details you are referred to: http://www.elsevier.com/authorsrights.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding source(s) had no such involvement then this should be stated. Please see http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies.
Sponsored articles
Sponsored Articles
Molecular & Biochemical Parasitology offers authors the option to sponsor non-subscriber access to their articles on Elsevier's electronic publishing platforms. For more information please view our Sponsored Articles page.
Language and language services
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission please visit http://www.elsevier.com/languageediting or our customer support site at http://epsupport.elsevier.com for more information.
Referees
Please submit, with the manuscript, the names, addresses and e-mail addresses of 3 potential referees. Note that the editor retains the sole right to decide whether or not the suggested reviewers are used.
Additional information
Publication in Molecular and Biochemical Parasitology is taken to imply the authors' willingness to comply with reasonable requests to supply reagents such as recombinant clones and monoclonal antibodies, and sequence data in electronic form to persons lacking access to computer databases.
Distribution of Materials and Data
One of the terms and conditions of publishing in Molecular and Biochemical Parasitology is that authors be willing to distribute any materials and protocols used in the published experiments to qualified researchers for their own reasonable use. Materials include but are not limited to cells, DNA, antibodies, reagents, vectors, constructs, organisms, and mouse strains. If quantities allow, these must be made available with minimal restrictions and in a timely manner, but it is acceptable to request reasonable payment to cover the cost of maintenance and transport of materials. If there are restrictions to the availability of any materials, data, or information, these must be disclosed in the cover letter and the Materials and Methods section of the manuscript at the time of submission.
Authors who produce reagents that are suitable for the study of malaria parasites are strongly encouraged to deposit these with the Malaria Research and Reference Reagent Resource Center [ www.MR4.org].
Use of wordprocessing software
It is important that the file be saved in the native format of the wordprocessor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. Do not embed "graphically designed" equations or tables, but prepare these using the wordprocessor's facility. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier: http://www.elsevier.com/guidepublication). Do not import the figures into the text file but, instead, indicate their approximate locations directly in the electronic text and on the manuscript. See also the section on Electronic illustrations.
To avoid unnecessary errors you are strongly advised to use the "spell-check" and "grammar-check" functions of your wordprocessor.
Article structure
Subdivision - numbered sections
Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this numbering also for internal cross-referencing: do not just refer to "the text". Any subsection may be given a brief heading. Each heading should appear on its own separate line.
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.
Material and methods
Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.
Results
Results should be clear and concise.
Discussion
This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature.
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section.
Appendices
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on.
Essential title page information
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
• Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name, and, if available, the e-mail address of each author.
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address.
• Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a "Present address" (or "Permanent address") may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract
A concise and factual abstract is required. The abstract should state briefly the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.
Graphical abstract
"NOTE regarding the mandatory Graphical Abstract:
The Graphical Abstract should allow readers to quickly gain an understanding of the main take-home message of the paper and is intended to encourage browsing, promote interdisciplinary scholarship, and help readers identify more quickly which papers are most relevant to their research interests. It should summarise the contents of the paper in a concise, pictorial form designed to capture the attention of a wide readership online. Authors must provide images that clearly represent the work described in the paper. Graphical abstracts should be uploaded as an individual/separate file.
The graphical abstract should comprise the title, authors and affiliations, identical to the article itself, a summary of about 25 words, and a pictogram [one figure representative of the work described]. Graphical abstracts will be collated to provide a contents list for rapid scanning. Ideally, the graphical abstract should be uploaded in full colour rather than in black and white, to make it as visually interesting as possible. While a key, summarising figure taken from the original paper can be submitted as a graphical abstract, it should be noted that it does not need to be an image from the manuscript itself.
Specifications for Graphical Abstracts
- Maximum image size 400x600 pixels (hxw, recommended size 200 x 500 pixels
- Use Arial font with a size of 10-16 points
- Preferred file types TIFF, EPS, PDF or MS Office files
- Visualise one process or make one point clear
- For ease of browsing, images should have a clear start and end, ideally " reading" from top to bottom or left to right
- Avoid distracting graphics or cluttered material as much as possible.
See http://www.elsevier.com/graphicalabstracts for examples.
NOTE: The cover images of future issues will be selected from the graphical abstracts of the papers within that issue.
Research highlights
Research highlights are mandatory for this journal. They consist of a short collection of bullet points that convey the core findings of the article and should be submitted in a separate file in the online submission system. Please use 'Research highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters per bullet point including spaces). See http://www.elsevier.com/researchhighlights for examples.
Keywords
Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, "and", "of"). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.
Abbreviations
Define abbreviations that are not standard in this field in a footnote to be placed on the first page of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article.
Abbreviations, symbols, chemical and biochemical nomenclature, etc., should follow the recommendations given in the Journal of Biological Chemistry (Vol. 272, pp. 28165-28170; http://www.jbc.org). Avoid abbreviations which are not in common use across the field of molecular and biochemical parasitology. Those used should be defined in the text on first usage and listed as a footnote on the title page. Do not introduce abbreviations unless they are used at least 4 times.
Genetic nomenclature for Trypanosoma and Leishmania should follow the guidelines proposed by Clayton et al (1998), Mol Biochem Parasitol 1998;97:221-224 ( http://www.elsevier.nl/cas/tree/store/molbio/free/1998/97/1-2/3178.pdf).
Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).
Accession numbers
Accession numbers are unique identifiers in bioinformatics allocated to nucleotide and protein sequences to allow tracking of different versions of that sequence record and the associated sequence in a data repository [e.g., databases at the National Center for Biotechnical Information (NCBI) at the National Library of Medicine ('GenBank') and the Worldwide Protein Data Bank]. There are different types of accession numbers in use based on the type of sequence cited, each of which uses a different coding. Authors should explicitly mention the type of accession number together with the actual number, bearing in mind that an error in a letter or number can result in a dead link in the online version of the article. Please use the following format: accession number type ID: xxxx (e.g., MMDB ID: 12345; PDB ID: 1TUP). Note that in the final version of the electronic copy, accession numbers will be linked to the appropriate database, enabling readers to go directly to that source from the article.
Footnotes
Footnotes should be used sparingly. Number them consecutively throughout the article, using superscript Arabic numbers. Many wordprocessors build footnotes into the text, and this feature may be used. Should this not be the case, indicate the position of footnotes in the text and present the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference list.
Table footnotes
Indicate each footnote in a table with a superscript lowercase letter.
Artwork
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as "graphics" or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork is finalised, please "save as" or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save the text as "graphics".
TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications please supply "as is".
Please do not:
• Supply embedded graphics in your wordprocessor (spreadsheet, presentation) document;
• Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Color artwork
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in the printed version. For color reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for color in print or on the Web only. For further information on the preparation of electronic artwork, please see http://www.elsevier.com/artworkinstructions.
Please note: Because of technical complications which can arise by converting color figures to "gray scale" (for the printed version should you not opt for color in print) please submit in addition usable black and white versions of all the color illustrations.
Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Tables
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere in the article.
References
Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either "Unpublished results" or "Personal communication" Citation of a reference as "in press" implies that the item has been accepted for publication.
Web references
As a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list.
References in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations in the text) to other articles in the same Special Issue.
Reference style
Text: Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s) must always be given.
List: Number the references (numbers in square brackets) in the list in the order in which they appear in the text.
Examples:
Reference to a journal publication:
[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun 2000;163:51–9.
Reference to a book:
[2] Strunk Jr W, White EB. The elements of style. 3rd ed. New York: Macmillan; 1979.
Reference to a chapter in an edited book:
[3] Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc; 1999, p. 281–304.
Note shortened form for last page number. e.g., 51–9, and that for more than 6 authors the first 6 should be listed followed by "et al." For further details you are referred to "Uniform Requirements for Manuscripts submitted to Biomedical Journals" (J Am Med Assoc 1997;277:927–934) (see also http://www.nlm.nih.gov/bsd/uniform_requirements.html).
Journal abbreviations source
Journal names should be abbreviated according to
Index Medicus journal abbreviations: http://www.nlm.nih.gov/tsd/serials/lji.html;
List of serial title word abbreviations: http://www.issn.org/2-22661-LTWA-online.php;
CAS (Chemical Abstracts Service): http://www.cas.org/sent.html.
Video data
Elsevier accepts video material and animation sequences to support and enhance your scientific research. Authors who have video or animation files that they wish to submit with their article are strongly encouraged to include these within the body of the article. This can be done in the same way as a figure or table by referring to the video or animation content and noting in the body text where it should be placed. All submitted files should be properly labeled so that they directly relate to the video file's content. In order to ensure that your video or animation material is directly usable, please provide the files in one of our recommended file formats with a maximum size of 10 MB. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. Please supply 'stills' with your files: you can choose any frame from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the link to your video data. For more detailed instructions please visit our video instruction pages at http://www.elsevier.com/artworkinstructions. Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and the print version for the portions of the article that refer to this content.
Supplementary data
Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please provide the data in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
Submission checklist
It is hoped that this list will be useful during the final checking of an article prior to sending it to the journal's Editor for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One Author designated as corresponding Author:
• E-mail address
• Full postal address
• Telephone and fax numbers
All necessary files have been uploaded
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been "spellchecked" and "grammar-checked"
• References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print or to be reproduced in color on the Web (free of charge) and in black-and-white in print
• If only color on the Web is required, black and white versions of the figures are also supplied for printing purposes
For any further information please visit our customer support site at http://epsupport.elsevier.com.
Additional information
Short communications and Technical Reports
These are intended for the publication of brief definitive reports, sequence data, methods, biochemical or immunochemical data that do not merit a full-length publication.
Short communications have similar subject scope to the full-length papers, while short technical reports concern mainly methods and reports of completed DNA sequencing projects.
Short communications and short technical reports are no more than four pages long including everything, with maximally two figures, one table and a maximum of 20 references. A single page contains about 900 words. Only the salient points of a long DNA sequence should be published, as the whole sequence will be available for a computer database. The title, authorship, affiliations, and an abstract not exceeding 150 words will be in the standard format of the journal. The text should not be sectioned, except for references. Essential experimental details may be incorporated into a figure legend. To facilitate rapid publication, authors will be expected to supply high-quality copy and expedite any necessary revisions.
Minireviews
Minireviews are by invitation only. Potential topics of general current interest should be submitted to the senior editor for consideration. Reviews should be short, current, specific and potentially provocative. They should provide a balanced synthesis from the available data rather than a comprehensive regurgitation of the literature. If possible, they should provide new concepts and ideas extending across different parasite systems. Reviews are restricted to about 4000 words, at most three display items including figures and tables and a list of references of not more than 50. The text can be divided into simple subsections with a succinct abstract. Minireviews will undergo the established review process at MBP, and will be published by an accelerated schedule if accepted.
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. The correct format for citing a DOI is shown as follows (example taken from a document in the journal Physics Letters B):
doi:10.1016/j.physletb.2003.10.071
When you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed never to change.
Proofs
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 (or higher) available free from http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how to annotate PDF files will accompany the proofs (also given online). The exact system requirements are given at the Adobe site: http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win.
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by post. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure that all of your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article if no response is received.
Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. The PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use.
For inquiries relating to the submission of articles (including electronic submission where available) please visit this journal's homepage. You can track accepted articles at http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when an article's status has changed. Also accessible from here is information on copyright, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher.
Editorial Board
Editors:
P.T. LoVerde
| Dept. of Biochemistry and Pathology, University of Texas Health Sciences Center at San Antonio, Mail Code 7760, San Antonio, TX 78229-3900, USA, Email: loverde@uthscsa.edu |
K.R. Matthews
| Inst. of Immunology and Infection Res., Sch. of Bio. Sci., University of Edinburgh, Wst Mains Road, Edinburgh, EH9 3JT, UK, Email: keith.matthews@ed.ac.uk |
M. Parsons
| Seattle Biomedical Research Institute, 307 Westlake Ave. N. Ste. 500, Seattle, WA 98109, USA, Email: marilyn.parsons@sbri.org |
A.P. Waters
| Inst. of Biomedical Life Sciences, Glasgow Biomedical Research Centre, University of Glasgow, 120 University Place, Glasgow, G12 8TA, UK, Email: Waters@bio.gla.ac.uk |
Reviews Editor:
A.G. Craig
| School of Tropical Medicine, University of Liverpool, Pembroke Place, Liverpool, L3 5QA, UK, Fax: +44 151 7053371, Tel: +44 151 7053161, Email: agcraig@liverpool.ac.uk |
Editorial Board:
D. Allred
| University of Florida, Gainesville, FL, USA |
J. Bangs
| University of Wisconsin at Madison, Madison, WI, USA |
J.D. Barry
| University of Glasgow, Glasgow, UK |
V. Bellofatto
| University of Medicine and Dentistry New Jersey (UMDNJ), Newark, NJ, USA |
M. Berriman
| The Sanger Institute, Cambridge, UK |
S. Beverley
| Washington University School of Medicine, St. Louis, MO, USA |
M. Blaxter
| University of Edinburgh, Edinburgh, UK |
J.C. Boothroyd
| Stanford University School of Medicine, Stanford, USA |
M. Carrington
| University of Cambridge, Cambridge, UK |
N. Carter
| Oregon Health and Sciences University (OHSU), Oregon, OR, USA |
J.J. Cazzulo
| Universidad de San Martin, Buenos Aires, Argentina |
C. Chitnis
| ICGEB - India, New Dehli, India |
C.G. Clark
| University of London, London, UK |
C.E. Clayton
| Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany |
R.L. Coppel
| Monash University, Melbourne, Australia |
A.F. Cowman
| Walter and Eliza Hall Institute of Medical Research (WEHI), Parkville, VIC, Australia |
G.A.M. Cross
| Rockefeller University, New York, NY, USA |
R. Docampo
| University of Georgia, Athens, GA, USA |
J.E. Donelson
| University of Iowa, Iowa City, IA, USA |
A.O. Egiza
| Southwest Foundation for Biomedical Research, San Antonio, TX, USA |
M.A.J. Ferguson
| University of Dundee, Dundee, UK |
A. Günzl
| University of Connecticut Health Center, Farmington, CT, USA |
K. Haldar
| Northwestern University, Chicago, IL, USA |
A.A. Holder
| Medical Research Council (MRC), The Ridgeway Mill Hill, London, UK |
D. Horn
| London School of Hygiene and Tropical Medicine, London, UK |
J. Jardim
| McGill University, Ste-Anne de Bellevue, QC, Canada |
D.J. Kemp
| Queensland Institute of Medical Research, Brisbane, QLD, Australia |
M.W. Kennedy
| University of Glasgow, Glasgow, UK |
K. Kim
| Columbia University, Bronx, NY, USA |
P. Köhler
| Universität Zürich, Zürich, Switzerland |
R. Komuniecki
| University of Toledo, Toledo, OH, USA |
S.M. Landfear
| Oregon Health and Sciences University (OHSU), Oregon, OR, USA |
S. Lustigman
| New York Blood Center, New York, NY, USA |
D.P. McManus
| Queensland Institute of Medical Research, Brisbane, QLD, Australia |
J.C. Mottram
| University of Glasgow, Glasgow, UK |
M. Muller
| Rockefeller University, New York, NY, USA |
M. Ouellete
| Centre de Recherche en Infectiologie du CHUL, Quebec City, QC, Canada |
E.J. Pearce
| University of Pennsylvania School of Medicine, Philadelphia, PA, USA |
P.K. Rathod
| University of Washington, Seattle, WA, USA |
P.J. Rosenthal
| University of California at San Francisco (UCSF), San Francisco, CA, USA |
M.E. Selkirk
| Imperial College, London, UK |
W. Sirawaraporn
| Mahidol University, Bangkok, Thailand |
D.F. Smith
| University of York, York, UK |
E. Tannich
| Bernhard Nocht Inst., Hamburg, Germany |
A.G.M. Tielens
| Universiteit Utrecht, Utrecht, Netherlands |
C. Tschudi
| Yale University School of Medicine, New Haven, CT, USA |
C.M.R. Turner
| University of Glasgow, Glasgow, UK |
B. Ullman
| Oregon Health and Sciences University (OHSU), Oregon, OR, OR, USA |
E. Ullu
| Yale University, New Haven, CT, USA |
T.R. Unnasch
| University of Alabama at Birmingham, Birmingham, AL, USA |
|
